World Journal of Pharmaceutical
Science and Research

An International Peer Reviewed Journal for Science & Pharmacy Professional


Login | Registration


ISSN: 2583-6579


Impact Factor: 5.111

ABSTRACT

DRUG SAFETY EVALUATION IN SPECIAL POPULATION

Jakka Lalitharani*, Tangi Sravani, Yallapu Durga Kusuma, Garikimukkula Sushma, Shaik Parveen, Manda Mariya

Pharmacovigilance is the scientific discipline that focuses on the detection , assessment , understanding , and prevention of adverse effects or any other drug related problems. It plays a crucial role in e nsuring the safety and efficacy of medications throughout their lifecycle, particularly after they have been approved for use by regulatory authorities. While the primary goal of pharmacovigilance is to detect and understand adverse drug reactions (ADRs), it also includes the broader task of improving public health by ensuring that the benefits of a drug outweigh its risks . This is critical because even after a drug is marketed and widely used, new safety issues can emerge when the drug is exposed to a lar ger and more diverse population.

[Full Text Article]

TRACK ARTICLE

NEWS

  • Impact Factor Increased

    We are pleased to inform you that our IMPACT FACTOR has increased from 3.454 to 5.111

    Email & SMS Alert

    We will provide you email alerts regarding New Issue Release, Publication of your Article, Invitaion for New Upcoming Issue, Manuscript releted Emails etc.

    December 2024 Issue Published

    Its Our pleasure to inform you that, WJPSR December 2024 Issue has been Published, Kindly check it on Click here

    Indexing

    This journal is indexed in world wide reputed commettee like: "DOI for all Articles" "Google Scholer" "SJIF Impact Factor:- 5.111" "Cosmos Impact Factor" "ISI Indexing" "International Impact Factor Services (IIFS)" "ResearchBib" etc.

    Article Invite for Publication

    Dear Researcher, Article Invited for Publication  in WJPSR Coming Issue.

    If you wish to Publish your Article in WJPSR Coming" December 2024 " Issue, 

    Submit it as soon as possible.